Clinical Trials of COVID-19 Vaccines by Russia’s Biocad, Generium to Start in June

MOSCOW (Sputnik) — Clinical trials of the first COVID-19 vaccines developed by the Russian pharmaceutical companies Biocad and Generium should start in June, Industry and Trade Minister Denis Manturov said on Monday.

«In June, clinical trials of the first vaccines developed by our pharmaceutical companies Biocad and Generium, together with leading scientific organisations of the Health Ministry and Rospotrebnadzor [the public health watchdog], should start», Manturov said at a meeting of the COVID-19 response coordinating council.

In the meantime, multiple countries are conducting research to create a vaccine against the disease, which has already infected over 6,000,000 people globally and claimed over 372,000 lives.

A source

Похожие статьи

Добавить комментарий

Ваш адрес email не будет опубликован. Обязательные поля помечены *

Кнопка «Наверх»